News and Trends 22 Jun 2021 Huge Series A in France Strengthens European Epigenetic Oncology Mnemo Therapeutics has raised €75M in the largest-ever French Series A round, which it will use to develop CAR-T cell immunotherapies for cancer using epigenetic targets. Mnemo Therapeutics’ mammoth financing, led by Casdin Capital, returning investor Sofinnova Partners, and an undisclosed investor, will allow the startup to accelerate the development of its epigenetic targeting and […] June 22, 2021 - 4 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2020 Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers The Netherlands-based food technology company Mosa Meat has raised €62M in a Series B round that will be used to bring its cultured beef products a step closer to the market. The funding round was led by the Luxembourg firm Blue Horizon Ventures in collaboration with the Bell Food Group, M Ventures, and others. Of […] October 2, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jul 2020 Life Sciences Fund Launches with €76M to Invest in Nordic Biotech Stockholm and Copenhagen-based Eir Ventures has announced the closure of its first fund at €76M, which will be used to invest in biotechs and other life science companies, with a focus on the Nordics. The fund is backed by Saminvest, a venture capital company founded by the Swedish Government; Vækstfonden, the Danish state’s investment fund; […] July 10, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jul 2020 CRISPR Therapeutics Announces Huge €400M Public Fundraise The Swiss firm CRISPR Therapeutics has priced a public offering on the Nasdaq Global Market at around €400M, which it will use to develop therapies based on the gene editing tool CRISPR/Cas9 for genetic disorders and cancer. This fundraise is the second-highest global share offering from a European biotech so far this year after the […] July 3, 2020 - 2 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2020 Epidarex Capital Targets UK Biotech with €112M Venture Fund The transatlantic life science VC Epidarex Capital has closed its third fund at a value of €112.7M, which will be used to build new biotech companies from emerging hubs across the UK. The ‘Epidarex Capital III UK LP’ fund is based on a €55.2M (£50M) commitment from the British Business Bank. The remainder comes from […] June 22, 2020 - 2 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2020 Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market — 20% above its initial target — to fund an ongoing phase III trial of its lead candidate treatment for an inflammatory kidney condition. Calliditas plans to use the net proceeds together with its existing cash resources to fund an […] June 5, 2020 - 2 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2020 French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring its lead RNA immunotherapy candidate to clinical trials in people with bladder cancer. The round was closed on the basis of the company reaching preclinical proof-of-concept for the drug. It brings the total amount raised by Tollys to €6.4M since […] May 28, 2020 - 2 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2020 Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products The German companies Evonik and Beiersdorf will work together on a joint research project to investigate how bacteria can be used to turn carbon dioxide (CO₂) and water into raw materials for skincare products. The process will be built on Evonik’s artificial photosynthesis technology – being developed independently of this project in collaboration with Siemens […] May 25, 2020 - 2 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2020 Affibody Signs €208M Deal To Market Autoimmune Drug in China Swedish biotech Affibody and Chinese firm Inmagene Biopharmaceuticals will work together to develop and commercialize Affibody’s phase II-stage drug for autoimmune diseases such as psoriasis. Under the agreement, Inmagene will commercialize Affibody’s treatment in the Greater China region and South Korea, as well as develop the drug in the Asia Pacific region excluding Japan. Meanwhile, […] May 15, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2020 Update: ADC Therapeutics’ IPO Hits Above Target with €215M Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York Stock Exchange far above the initial target of €172M, raising a total of €215.2M ($232.7M). ADC Therapeutics ended up offering more than 12 million shares at a price of €17.57 ($19) per share, which was higher than the €16.65 ($18) […] May 15, 2020 - 4 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2020 €7M Series A To Democratize Genomics with AI-Driven Cloud Software The UK-based bioinformatics firm Lifebit Biotech has closed a €7M Series A funding round, which will help the startup to accelerate the global market expansion of its AI-driven, cloud-based genomics analysis software. The round was led by the Parisian VC firm Idinvest Partners and also included returning investors Pentech Ventures, Beacon Capital, and Connect Ventures. […] May 8, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 24 Apr 2020 Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop a new generation of drugs that target DNA repair in cancer cells. The drugs will block a DNA repair process called break-induced replication, which was discovered by the company’s scientific founder Thanos Halazonetis. This process is used by cancer cells […] April 24, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email